mRNAs (messenger RNAs) are an emerging class of therapeutic agents for the prevention and treatment of a wide range of diseases. As the world's leading manufacturer of custom mRNA synthesis, CD Formulation is committed to providing high-quality nucleic acid products and custom synthesis services for molecular biology research, diagnostics, and therapeutic applications. Leveraging a robust technology platform, state-of-the-art cGMP-grade manufacturing facilities, and cutting-edge mRNA synthesis technology, we offer custom mRNA synthesis services ranging from micrograms to hundreds of grams for customers worldwide.
mRNAs play a pivotal role in the development of novel therapeutics and vaccines. mRNA molecules encode specific proteins and trigger targeted cellular responses, making them versatile tools for biomedical research and clinical applications.
Fig.1 Advantages of mRNA as Nucleic Acid Formulation. (CD Formulation)
CD Formulation is a recognized leader in the biotechnology industry, offering a comprehensive range of custom mRNA synthesis services and delivering innovative solutions to meet the varied requirements of researchers, pharmaceutical companies, and biotechnology firms.
Items | Descriptions |
---|---|
|
Our company specializes in the synthesis of custom mRNA vaccines, which have the potential to revolutionize immunization programs. Our team of experts collaborates closely with customers to design and synthesize mRNA molecules encoding the relevant antigens. |
|
The therapeutic potential of mRNA extends to the treatment of genetic disorders, cancer, and other chronic diseases. Our services in custom mRNA therapeutic synthesis include designing mRNAs that can correct or regulate gene expression in patients' cells. |
|
In addition to vaccines and therapeutics, mRNA technology enables the generation of biopharmaceuticals in the human body. With our expertise in mRNA synthesis, we can help design, synthesize, and optimize mRNA drugs. |
CD Formulation's mRNA synthesis services are supported by state-of-the-art solutions that guarantee the accuracy, scalability, and efficiency of custom mRNA molecule production. We employ advanced technologies and rigorous quality control measures to cater to the diverse needs of our clients.
Fig. 2 In Vitro Transcribed (IVT) mRNA Production. (Linares-Fernández S. et al., 2020)
mRNAs are designed to achieve specific goals (including expression, delivery and stability of target proteins, immunogenicity, etc.), such as the production of specific proteins or the activation of an immune response. Our extensive experience in mRNA design allows us to meet the requirements of customers.
For mRNA synthesis, we normally use in vitro transcription (IVT) technology. The main process of preparation is as follows.
Using DNA containing the sequence of T7 promoter (TAATACGACTCACTATAGGG) or SP6 promoter (ATTTAGGTGACACTATAG) as a template, mRNA molecules complementary to one strand of the template DNA are synthesized using NTP as a substrate in the presence of T7 or SP6 RNA polymerase. Finally, the stability of the mRNA can be enhanced by adding a cap structure at the 5' end or a poly(A) tail at the 3' end.
After rigorous synthesis and modification, the resulting mRNA needs to be further purified to meet purity standards for subsequent studies. CD Formulation offers specialized purification technologies that remove excess immunostimulatory contaminants, free ribonucleotides, short mRNAs, and DNA templates.
Preparation Technology | In Vitro Transcription (IVT) Technology | Cell-based Transcription Technology | Chemical Synthesis Technology |
---|---|---|---|
Specification | The technology uses RNA polymerase to synthesize mRNA in vitro. It offers controllable reaction conditions, high synthesis efficiency and large-scale production. | This technology carries out mRNA synthesis and maturation processing in cells, which can produce more natural mRNA molecules. | The technology utilizes chemical methods to directly synthesize mRNA nucleotide sequences, enabling precise control over the structure and sequence of mRNA. |
Technology: Preparation of mRNA by in vitro transcription technology
Journal: Biomaterials
IF: 12.479
Published: 2018
Results:
The authors review the current state of research on the synthesis of IVT mRNA and its chemical modification. They describe DNA template design, the IVT process, and the purification of mRNA in detail. The large-scale production of synthetic mRNA for clinical applications is also elaborated upon. Furthermore, the therapeutic applications of IVT mRNA in the fields of cell reprogramming, stem cell engineering, and protein replacement therapy are emphasized. These studies provide strong support for the clinical potential of IVT mRNA and its versatility in regenerative medicine. Finally, the authors discuss the current limitations and future perspectives of IVT mRNA, providing important guiding factors for the development of mRNA-based therapies.
Fig. 3 Preparation of synthetic mRNA by in vitro transcription (IVT). (Kwon H. et al., 2018)
CD Formulation is dedicated to providing customers with mRNA synthesis services and offers a wide range of characterization techniques for these nucleic acid drugs. These services can be utilized holistically to assist customers in developing their projects in the drug therapy industry. If you are interested in our services, please get in touch with us.
References